J.&J. Vaccine Recipients May Benefit From Different Booster, Study Says

A separate study from the F.D.A. suggested that Johnson & Johnson had submitted weak data for boosters. Catch up on Covid-19 news.,A separate study from the F.D.A. suggested that Johnson & Johnson had submitted weak data for boosters. Catch up on Covid-19 news.

Leave a Reply